GSK appoints six directors to Haleon Board

16 March 2022 - Deborah Wilkes

Premium

GlaxoSmithKline (GSK) has appointed six directors to the Board of Haleon, the standalone company that will be formed through the planned demerger of GSK Consumer Healthcare in July 2022.

Click tags below for more information on topics:

GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: